FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Wockhardt news from FiercePharma

Most Popular Wockhardt story
Related Tags GlaxoSmithKline   India   Biogen Idec   Merck Kgaa
Tools

News

ALSO NOTED: Wockhardt gets OK for Zithromax copy; Depomed's gabapentin formula passes Phase II;

February 12, 2008 — 7:59am ET
> Wockhardt got the FDA nod to sell a copycat form of Pfizer's Zithromax, an antibiotic. Report >... Read more...

ALSO NOTED: Forest sues generics over Namenda; Omrix gets new indication for Evicel;

January 11, 2008 — 7:59am ET
> Forest Labs and Merck KGaA are suing several generics makers--including Barr, Cobalt, Lupin, Orchid, Teva, and Wockhardt--for infringing patents on the Namenda treatment for Alzheimer's. Read more...

ALSO NOTED: Barr challenges Sanofi patents on $1.1B drug; Wockhardt to launch copycat Zoloft;

January 9, 2008 — 7:59am ET
> Barr Laboratories is challenging Sanofi-Aventis patents on Eloxatin, a colon-cancer drug that Barr wants to copy; Eloxatin posted $1.1 billion in U.S. sales for the 12 months ended in October.... Read more...

ALSO NOTED: Sepracor chair to retire in May; Study shows Glaxo drug outpacing Pfizer's Spiriva;

January 2, 2008 — 7:59am ET
> Sepracor chairman Timothy Barberich will retire by May, according to a disclosure filed with the Securities and Exchange commission; Barberich is the drug maker's former CEO. Read more...

ALSO NOTED: GSK suing Abbott over HIV-drug price; Harvard genius joins MIT-Novartis effort;

November 12, 2007 — 7:59am ET
> GlaxoSmithKline is joining a lawsuit against Abbott Laboratories over the jacked-up price of Norvir, and anti-HIV drug. Read more...

ALSO NOTED: Strong euro hitting Merck KGaA's revenue; U.S. sales boost Lupin's Q3 profits;

October 24, 2007 — 6:59am ET
> German pharma Merck KGaA says a strong euro will depress its year-end sales; it reported a 74.9 percent drop in third-quarter profits on a one-time charge from its acquisition of Serono. Read more...

ALSO NOTED: Layoffs depress J&J profits; Canada OKs Pfizer HIV med;

October 16, 2007 — 6:59am ET
> Pink slips cost money. Just ask Johnson & Johnson, which saw its third-quarter profits drop by 8 percent because of money spent cutting jobs. Read more...

Rumor Mill: Indian drug makers court Par

September 18, 2007 — 6:59am ET
At least three Indian drug makers were spotted with chocolate and flowers at the headquarters of Par Pharmaceuticals, one of the top 10 generics companies in the U.S. Several Indian newspapers are... Read more...

SPOTLIGHT: Orion battles generic

September 14, 2007 — 6:59am ET
Finnish drug maker Orion says it's suing Indian generics maker Wockhardt to keep the latter's version of the Parkinson's drug Comtan off the market. Read more...

Get more Wockhardt coverage at:

FierceBiotech